A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
about
Levofloxacin for the treatment of respiratory tract infections.Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study.Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization.Are fluoroquinolones superior antibiotics for the treatment of community-acquired pneumonia?
P2860
A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A comparison of levofloxacin a ...... e US: focus on length of stay.
@en
A comparison of levofloxacin a ...... d community-acquired pneumonia
@nl
type
label
A comparison of levofloxacin a ...... e US: focus on length of stay.
@en
A comparison of levofloxacin a ...... d community-acquired pneumonia
@nl
prefLabel
A comparison of levofloxacin a ...... e US: focus on length of stay.
@en
A comparison of levofloxacin a ...... d community-acquired pneumonia
@nl
P2093
P356
P1476
A comparison of levofloxacin a ...... he US: focus on length of stay
@en
P2093
Carmela Janagap-Benson
Dilesh Doshi
Jeff Schein
Vanja Sikirica
William Olson
P304
P356
10.1185/030079908X273408
P407
P577
2008-03-01T00:00:00Z